Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas. Show more

6801 N. CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX, UNITED STATES, 78731, Austin, TX, 78731, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

115M

52 Wk Range

$1.20 - $4.98

Previous Close

$2.38

Open

$2.38

Volume

N/A

Day Range

$2.38 - $2.38

Enterprise Value

-23.77M

Cash

86.57M

Avg Qtr Burn

-8.878M

Insider Ownership

12.79%

Institutional Own.

28.98%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Simufilam Details Tuberous Sclerosis Complex (TSC)-related epilepsy	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Simufilam (PTI-125) Details Alzheimer's disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.